Progress in personalized immunotherapy for patients with brain metastasis

Area of Science:

• Neuro-oncology
• Immunology
• Cancer Research

Background:

• Brain metastases are a major cause of cancer-related morbidity and mortality.
• Central nervous system (CNS) injury from brain tumors severely impacts patient survival and quality of life.
• Understanding the tumor immune microenvironment is crucial for developing effective cancer therapies.

Purpose of the Study:

• To review the current understanding of the immune landscape in brain metastases.
• To summarize existing and emerging therapeutic strategies, including immunotherapies.
• To highlight the challenges of immunotherapy resistance and the need for personalized approaches.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of current treatment modalities for brain metastases.
• Exploration of clinical trials investigating novel therapies.

Main Results:

• Immunotherapy offers potential benefits but faces significant resistance in the brain metastasis setting.
• The tumor immune microenvironment in brain metastases is complex and heterogeneous.
• Current therapies including surgery, chemotherapy, and radiation have limitations.

Conclusions:

• Optimizing outcomes for brain metastases requires a deeper understanding of the immune microenvironment.
• Personalized, biomarker-driven strategies are essential to overcome immunotherapy resistance.
• Future research should focus on novel therapeutic combinations and predictive biomarkers.